Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Reduce allergy sits at the center of this dementia and brain health question.
Yes, Singulair (montelukast) can be used to reduce allergy symptoms, particularly for allergic rhinitis, also known as hay fever. The FDA approved this medication in 1998 for treating allergic rhinitis in patients aged 2 years and older for seasonal allergies and 6 months and older for year-round allergies. However, it’s important to understand that while Singulair works for many people, medical experts recommend other allergy medications as first-line treatments in most cases.
For someone experiencing seasonal pollen allergies, Singulair might reduce nasal congestion, sneezing, and itchy eyes, but your doctor will likely suggest trying other options first before turning to this medication. Singulair belongs to a class of drugs called leukotriene receptor antagonists, and it operates differently than common antihistamine medications. Rather than blocking histamine, Singulair targets leukotrienes, which are chemical messengers in the body that trigger inflammation, airway tightening, and mucus production during allergic reactions. This different mechanism means it can be helpful for people who don’t respond well to standard antihistamines, though the medication comes with important safety considerations that every patient should understand before starting treatment.
Table of Contents
- How Does Singulair Work to Reduce Allergy Symptoms?
- Effectiveness and Safety Profile of Singulair
- Mental Health and Neurological Side Effects
- When Should Singulair Be Used for Allergies?
- Common Adverse Effects Beyond Mental Health
- Comparing Singulair to Other Allergy Medications
- Who Should Avoid Singulair and When to Speak With Your Doctor
- Conclusion
How Does Singulair Work to Reduce Allergy Symptoms?
Singulair works by blocking leukotrienes, which are powerful inflammatory chemicals released by immune cells in response to allergens. When you encounter an allergen—such as pollen, pet dander, or dust mites—your body’s immune system releases leukotrienes that cause the classic allergy symptoms: inflammation of the nasal passages, increased mucus production, and airway tightening. By blocking these chemicals, Singulair reduces the inflammation and mucus that cause congestion and post-nasal drip. This makes it particularly useful for people who experience year-round allergies or those whose allergy symptoms are severe enough to interfere with sleep and daily activities.
The medication typically takes longer to work than antihistamines; it may take several days or even a week to notice the full effect. For example, someone with seasonal allergies might need to start Singulair several weeks before spring pollen season arrives to achieve maximum benefit. This delayed onset distinguishes it from antihistamines like cetirizine or loratadine, which work within an hour. The leukotriene pathway is also involved in asthma, which is why Singulair is FDA-approved for both allergic rhinitis and asthma—it addresses a common underlying mechanism in both conditions.
Effectiveness and Safety Profile of Singulair
Clinical trials have demonstrated that Singulair effectively reduces allergy symptoms in many patients. The FDA evaluated the medication’s safety in 2,199 adult and adolescent patients aged 15 years and older in controlled clinical trials. In these studies, Singulair was generally well tolerated, though it’s important to note that some adverse events did occur more frequently in the treatment group than in placebo. For instance, upper respiratory infections were reported in 1.9% of Singulair users compared to 1.5% of the placebo group—a small but measurable increase.
More recent 2025 meta-analyses suggest that montelukast continues to improve allergic rhinitis symptoms with a favorable safety profile when compared to some alternative treatments. However, the FDA has determined that Singulair requires a boxed warning—the most serious type of warning the agency can require—regarding potential serious mental health side effects. These can include mood changes, depressive thoughts, and other neuropsychiatric effects. A Swedish cohort study analyzing data from 2007 to 2021 found that montelukast users experienced approximately 2.39 neuropsychiatric adverse events per 100 patient-years, which researchers noted was comparable to rates seen with other asthma and allergy treatments. Despite this comparison, the neuropsychiatric risks remain a significant concern and should be carefully discussed with your healthcare provider before starting the medication, especially if you have a personal or family history of depression or other mental health conditions.
Mental Health and Neurological Side Effects
The most concerning aspect of Singulair for many patients is its potential to cause serious mental health problems. The FDA’s boxed warning specifically highlights the risk of mood changes, thoughts of suicide, severe anxiety, agitation, and depression. These effects have been reported across different age groups, though the mechanisms behind why some patients experience them while others don’t remain not fully understood. For an older adult taking Singulair for allergies, particularly someone already dealing with age-related cognitive concerns or a history of depression, these risks warrant particular attention and close monitoring.
Beyond the serious neuropsychiatric events covered by the boxed warning, patients commonly report other mood-related side effects including irritability, sleep disturbances, and difficulty concentrating. A person might start Singulair for seasonal allergies and notice within days that they feel unusually anxious or that their sleep quality has deteriorated. Because these side effects can develop gradually, it’s easy to miss the connection to the medication. This is especially problematic for people with early cognitive decline or dementia, where distinguishing a medication side effect from the underlying condition becomes challenging. If you experience any mood changes, new anxiety, depression, or unusual thoughts while taking Singulair, you should contact your doctor immediately rather than stopping the medication suddenly.
When Should Singulair Be Used for Allergies?
According to medical guidelines and FDA guidance, Singulair for allergic rhinitis should generally only be considered when you cannot tolerate other allergy medications or when they have failed to control your symptoms adequately. This means your doctor would typically recommend trying antihistamines (like cetirizine or loratadine) or intranasal corticosteroids (like fluticasone) first before moving to Singulair. These other medications have longer safety records for allergy treatment and don’t carry the same boxed warning regarding neuropsychiatric effects.
Only after demonstrating that these first-line options don’t work or cause intolerable side effects would Singulair be an appropriate choice for allergy management. For someone with year-round allergies triggered by indoor allergens like pet dander or dust mites, the decision to use Singulair versus other options should include a careful discussion with your healthcare provider about your complete medical history, including any past or present mental health concerns. If you have underlying cognitive conditions or a family history of neuropsychiatric disorders, your doctor might recommend avoiding Singulair altogether in favor of safer alternatives. The convenience of a once-daily oral medication might appeal to some patients, but this advantage should be weighed carefully against the potential neuropsychiatric risks that make other allergy medications safer choices for most people.
Common Adverse Effects Beyond Mental Health
While mental health side effects receive the most attention due to the FDA boxed warning, Singulair causes other adverse effects that patients commonly experience. The most frequently reported side effects include upper respiratory infections, diarrhea, nausea, vomiting, and elevated liver enzymes. A patient taking Singulair might experience persistent diarrhea or mild nausea that gradually improves as their body adjusts to the medication, or these symptoms might persist throughout treatment. These gastrointestinal effects, while typically not serious, can be uncomfortable and may interact with other health conditions or medications in older adults.
Additionally, some patients report elevated liver enzyme levels during routine blood tests, which requires monitoring through periodic laboratory work. This is particularly important for people taking multiple medications or those with existing liver disease, as Singulair is metabolized by the liver. For an older adult or someone with other health conditions, this possibility of liver enzyme elevation adds another layer of complexity to the risk-benefit analysis. Your doctor would typically recommend baseline liver function tests before starting Singulair and periodic monitoring during treatment to catch any concerning changes early.
Comparing Singulair to Other Allergy Medications
When considering whether to use Singulair for allergies, it’s helpful to understand how it compares to more commonly recommended alternatives. Intranasal corticosteroids like fluticasone (Flonase) or mometasone work by reducing inflammation directly in the nasal passages and are typically recommended as first-line treatment for allergic rhinitis. They work faster than Singulair, usually within a few hours to a day, and have a well-established safety record specifically for allergy treatment.
For seasonal allergies, many people find that a corticosteroid nasal spray completely controls their symptoms without the neuropsychiatric concerns associated with Singulair. Second-generation antihistamines like cetirizine (Zyrtec) or loratadine (Claritin) offer another option with a rapid onset and predictable side effect profile—mainly drowsiness or dry mouth. These medications have been used safely for decades and don’t carry warnings about serious mental health effects. The choice between these standard allergy medications and Singulair should involve a conversation with your doctor about your specific allergy pattern, your response to previous allergy treatments, and your complete medical history, including any neuropsychiatric concerns.
Who Should Avoid Singulair and When to Speak With Your Doctor
Certain groups of people should avoid Singulair or use it only under very close medical supervision. Anyone with a personal history of depression, suicidal thoughts, or other serious mental health conditions should be especially cautious and should discuss the medication thoroughly with both their primary care doctor and, if applicable, their mental health provider. Older adults, particularly those with early cognitive decline or dementia, represent another group where the potential neuropsychiatric side effects are particularly concerning and where alternative allergy treatments would likely be safer.
Pregnant women and people with liver disease also require careful consideration and specialized medical guidance before using Singulair. Before starting Singulair, you should inform your doctor about all medications you’re taking, any previous allergic reactions to medications, and your complete medical history including any mental health concerns. If you’re already taking Singulair and experience any mood changes, new anxiety, depression, sleep problems, or unusual thoughts, contact your healthcare provider immediately. This is not a medication to stop abruptly on your own, but rather one where your doctor needs to be involved in any decisions about continuing, adjusting, or stopping treatment.
Conclusion
Singulair can reduce allergy symptoms in some patients, particularly those with allergic rhinitis who haven’t responded to or tolerated other allergy medications. It works through a different mechanism than common antihistamines by blocking leukotrienes, the inflammatory chemicals responsible for allergy symptoms. However, the FDA’s boxed warning about serious neuropsychiatric side effects—including mood changes, depression, and thoughts of suicide—makes this medication a second-line or later-line option rather than a first choice for allergies.
Before considering Singulair for allergies, work with your healthcare provider to ensure you’ve tried safer, first-line treatments like intranasal corticosteroids or antihistamines. If you do use Singulair, close monitoring for any mood or mental health changes is essential, especially if you have a personal or family history of depression or other psychiatric conditions. Your doctor can help you weigh the potential benefits of allergy symptom relief against the neuropsychiatric risks and can monitor your response to the medication over time, adjusting treatment as needed to keep you both comfortable and safe.
You Might Also Like
- Is Mucinex Nightshift Safe to Use for Allergy Symptoms?
- Why More Nursing Moms Are Reaching for Vicks VapoSteam
- Singers Reach for Quercetin for Stuffiness
For more, see Alzheimer’s Association — caregiving.
